Task: Answer the MCQ question.
Question: Which compound exhibits a -4.805\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CCCn1c(SCC(=O)N2CCN(c3ccccc3)CC2)nc2ccccc2c1=O
b. CCC1NC(C(=O)O)Cc2c1[nH]c1ccccc21
Answer: a. CCCn1c(SCC(=O)N2CCN(c3ccccc3)CC2)nc2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(SCC(=O)N2CCN(c3ccccc3)CC2)nc2ccccc2c1=O
CCCn1c(SCC(=O)N2CCN(c3ccccc3)CC2)nc2ccccc2c1=O
2-[2-oxo-2-(4-phenyl-1,4-diazinan-1-yl)ethyl]sulfanyl-3-propylquinazolin-4-one